Compare AU

Compare IHOO vs. CURE

Compare shares and ETFs on the ASX that you can trade on Pearler.

S&P Global 100 Multi-nationals (AUD Hedged)

ASX

Buy

Buy

Overview
Performance

Overview

When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the S&P Global 100 Multi-nationals (AUD Hedged) (IHOO) and the S&P US Biotech (CURE). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.

Community Stats

IHOO

CURE

Popularity

Low

Low

Pearlers invested

12

83

Median incremental investment

$1,020.50

$619.50

Median investment frequency

Fortnightly

Monthly

Median total investment

$7,362.80

$1,461.60

Average age group

> 35

> 35


Key Summary

IHOO

CURE

Strategy

IHOO.AX was created on 2014-12-15 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The ETF currently has 478.19m in AUM and 104 holdings. The fund aims to provide investors with the performance of the S&P Global 100 Hedged AUD Index, before fees and expenses. The index is designed to measure the AUD hedged performance of 100 multi-national, blue chip companies of major importance in global equity markets

CURE.AX was created on 2018-11-08 by Global X. The fund's investment portfolio concentrates primarily on health care equity. The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the S&P Biotechnology Select Industry Index.

Top 3 holdings

APPLE INC (12.53 %)

NVIDIA CORP (11.90 %)

MICROSOFT CORP (10.90 %)

Natera Inc (3.33 %)

Incyte Corp (2.95 %)

Gilead Sciences Inc (2.81 %)

Top 3 industries

Information Technology (41.20 %)

Health Care (10.04 %)

Consumer Discretionary (9.13 %)

Health Care (100.00 %)

Other (10.24 %)

Top 3 countries

United States (81.06 %)

United Kingdom of Great Britain and Northern Ireland (4.32 %)

Switzerland (3.26 %)

United States (97.17 %)

Switzerland (1.51 %)

United Kingdom of Great Britain and Northern Ireland (1.16 %)

Management fee

0.43 %

0.45 %


Key Summary

IHOO

CURE

Issuer

iShares

Global X

Tracking index

S&P Global 100 Hedged to AUD Index - AUD

S&P Biotechnology Select Industry

Asset class

ETF

ETF

Management fee

0.43 %

0.45 %

Price

$186.40

$52.00

Size

$486.061 million

$36.301 million

10Y return

N/A

N/A

Annual distribution yield (5Y)

5.07 %

4.24 %

Market

ASX

ASX

First listed date

18/12/2014

12/11/2018

Purchase fee

$6.50

$6.50


Community Stats

IHOO

CURE

Popularity

Low

Low

Pearlers invested

12

83

Median incremental investment

$1,020.50

$619.50

Median investment frequency

Fortnightly

Monthly

Median total investment

$7,362.80

$1,461.60

Average age group

> 35

> 35


Pros and Cons

IHOO

CURE

Pros

  • Higher exposure to AU market

  • Lower management fee

  • Higher price growth

  • Higher distribution yield

  • Higher exposure to US market

Cons

  • Lower exposure to US market

  • Lower exposure to AU market

  • Higher management fee

  • Lower price growth

  • Lower distribution yield

IHOO

CURE

Higher exposure to AU market

Lower exposure to AU market

Lower exposure to US market

Higher exposure to US market

Lower management fee

Higher management fee

Higher price growth

Lower price growth

Higher distribution yield

Lower distribution yield

Home